Bringing the fundamentals into focus…
Back to Opus Genetics, Inc.
How Opus Genetics, Inc. stacks up
IRD · against 379 other Healthcare companies of similar size
Overall
11/ 100
Near the bottom of its peers.
Ranked #373 of 380 · scores higher than 2% of peers
Bars: peers in each 10-point band of the overall score18 peers with an overall score of 10–19, including IRD · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around IRD| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 4 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 5 | 433M USD | 81 | 96 | 99 | 99 | 2 / 2 | |
| 369 | 222M GBP (≈$288M) | 13 | 18 | 17 | 2 / 2 | ||
| 369 | 354M USD | 13 | 8 | 9 | 6 | 2 / 2 | |
| 371 | 35.2B JPY (≈$240M) | 12 | 8 | 7 | 3 | 2 / 2 | |
| 371 | 522M USD | 12 | 8 | 13 | 19 | 2 / 2 | |
| 373 | 327M USD | 11 | 8 | 1 | 5 | 2 / 2 | |
| 374 | 2.3B CNY (≈$322M) | 10 | 0 | 3 | 31 | 2 / 2 | |
| 374 | 198M USD | 10 | 8 | 17 | 13 | 2 / 2 | |
| 376 | 2.1B CNY (≈$291M) | 9 | 0 | 3 | 24 | 2 / 2 | |
| 377 | 454M AUD (≈$299M) | 7 | 0 | 3 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score